POMA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 4.935
EU - Europa 2.508
AS - Asia 508
SA - Sud America 9
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.971
Nazione #
US - Stati Uniti d'America 4.922
IT - Italia 887
FI - Finlandia 455
UA - Ucraina 380
CN - Cina 368
IE - Irlanda 188
DE - Germania 156
GB - Regno Unito 132
SE - Svezia 101
RU - Federazione Russa 56
FR - Francia 48
TR - Turchia 48
IN - India 34
BE - Belgio 29
RO - Romania 16
KR - Corea 15
BG - Bulgaria 12
SG - Singapore 11
CH - Svizzera 10
AT - Austria 9
CZ - Repubblica Ceca 9
IR - Iran 8
HK - Hong Kong 7
VN - Vietnam 7
NL - Olanda 6
BR - Brasile 5
CA - Canada 5
MX - Messico 5
TN - Tunisia 4
EU - Europa 3
LB - Libano 3
MT - Malta 3
PE - Perù 3
EG - Egitto 2
ES - Italia 2
GR - Grecia 2
GT - Guatemala 2
JP - Giappone 2
NO - Norvegia 2
PK - Pakistan 2
PL - Polonia 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
EE - Estonia 1
GH - Ghana 1
LK - Sri Lanka 1
PA - Panama 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 7.971
Città #
Fairfield 702
Ashburn 409
Chandler 406
Houston 386
Woodbridge 379
Ann Arbor 331
Wilmington 303
Seattle 258
Palermo 255
Cambridge 226
Jacksonville 211
Dublin 183
Medford 138
Des Moines 129
Nanjing 91
Princeton 86
Boardman 78
Altamura 64
New York 57
Tulsa 56
San Diego 50
Lawrence 49
Beijing 48
Dearborn 43
Venice 32
Izmir 29
Nanchang 28
Brussels 27
Hebei 27
Ludwigshafen am Rhein 27
Shenyang 27
Bremen 25
Changsha 20
Milan 20
Falls Church 18
Helsinki 18
Jinan 18
London 16
Jiaxing 14
Ningbo 14
San Paolo di Civitate 14
Seongnam 14
Kumar 13
Rome 12
Saint Petersburg 12
Verona 12
Auburn Hills 11
Los Angeles 11
Sofia 11
Zhengzhou 10
Napoli 9
Salerno 9
San Mateo 9
Brescia 8
Catania 8
Guangzhou 8
Taizhou 8
Tianjin 8
Bologna 7
Capaci 7
Messina 7
Naples 7
Pune 7
Sanayi 7
Durham 6
Hangzhou 6
Kilburn 6
Kunming 6
Redwood City 6
Renton 6
Atlanta 5
Bengaluru 5
Haikou 5
Lanzhou 5
Nha Trang 5
Norwalk 5
San Giuliano Milanese 5
Shanghai 5
Singapore 5
Andover 4
Hong Kong 4
Orange 4
Phoenix 4
Tehran 4
Cuernavaca 3
Foggia 3
Hanover 3
Hefei 3
Innsbruck 3
Lappeenranta 3
Lima 3
Milpitas 3
Moscow 3
Olgiate Olona 3
Olomouc 3
Ortona 3
Santa Maria A Monte 3
Stockholm 3
Tappahannock 3
Viagrande 3
Totale 5.676
Nome #
Targeting Multiple Myeloma with natural polyphenols 205
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 183
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 177
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 170
Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems 167
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 167
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 163
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 160
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 155
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 152
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 151
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 150
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 149
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 145
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 143
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 140
Expression of the IAPs in multidrug resistant tumor cells 135
Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications 134
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 129
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 128
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 128
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 128
Unusual high dose of tacrolimus in liver transplant patient, a case report. 126
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 125
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 124
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 122
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 117
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 112
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 111
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 111
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 109
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 109
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 106
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 102
Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilisation and caspase-3 activation 101
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 101
Co-loaded cardanol/triazole-halloysite system: characterization of the supramolecular complex and evaluation of its antiproliferative activity 96
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 95
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 93
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 93
Significance of autologous interleukin 6 production in the HA22T/VGH model of hepatocellular carcinoma 92
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 92
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 89
Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives 86
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 85
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 84
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 82
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 78
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 76
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 74
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 72
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 71
SYNTHESIS AND CHARACTERIZATION OF POSITIVELY CHARGED FUNCTIONALIZED HALLOYSITE/CURCUMIN SYSTEMS AND EVALUATION OF THEIR ANTICANCER ACTIVITY 71
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 70
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 68
null 67
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 66
Caratterizzazione e valutazione dell’attività anti proliferativa di nuovi sistemi per il drug carrier Allosite-sali triazolici/cardanolo 65
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 64
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 63
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 63
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 62
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 62
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 60
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 60
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 59
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 59
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 58
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 56
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 56
Antitumor effects of curcumin and of its combinations with cisplatin or doxorubicin on human hepatic cancer cells: Possible relationship to NF-kB activation and IAP gene expression 56
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 55
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 54
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 54
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 54
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 53
Inhibitor of apoptosis proteins (IAPs) as new possible therapeutic targets in hepatocellular cancer 50
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 50
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 49
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 49
NF-κB is a potential pharmacological target in triple negative breast cancers. 47
Plant polyphenols as privileged multi-target compounds for chemo- and immuno-sensitization 43
NF-kB and Disease 41
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 38
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 38
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 37
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 36
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 34
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 32
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 31
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 28
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 19
A Curcumin-BODIPY Dyad and Its Silica Hybrid as NIR Bioimaging Probes 12
Totale 8.382
Categoria #
all - tutte 29.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 0 0 151
2019/20202.065 257 83 146 203 215 283 230 130 205 108 118 87
2020/20211.137 43 108 57 121 85 60 86 83 139 99 148 108
2021/20221.181 50 237 32 21 59 37 72 41 120 197 77 238
2022/20231.348 141 212 22 156 163 219 107 84 149 14 65 16
2023/2024645 51 98 50 27 38 139 48 48 14 36 40 56
Totale 8.382